Clinical trials: Cutibacterium Acnes

Acne Vulgaris

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

• Completed
• Age: 18 to 40 years
• Phase 2
• Results posted

This is a Phase 2a study which is being conducted in healthy volunteers in order to evaluate the comparative reduction of Propionibacterium acnes in-vivo following once daily topical administration of BPX-01 Minocycline 1%…

Trial name

NCT02709096

Testing

BPX-01, 1% Topical Gel, BPX-01 Vehicle Gel

Where

United States

Volunteers

33 people, healthy volunteers welcome

Sponsor

BioPharmX, Inc.